secwatch.observer — SEC 8-K summary
======================================

Issuer:     Greenwich LifeSciences, Inc. (GLSI)
CIK:        0001799788
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0001641172-25-020843
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Greenwich LifeSciences dismisses RBSM, hires MaloneBailey as auditor effective July 19, 2025
--------------------------------------------------------------------------------

- Audit committee approved dismissing RBSM LLP and engaging MaloneBailey LLP for fiscal 2025 audit.
- RBSM's reports for 2024 and 2023 were unqualified; no disagreements on accounting or auditing matters.
- Prior material weaknesses in internal control over financial reporting were discussed with RBSM and disclosed in earlier SEC filings.
- RBSM provided a letter to the SEC, attached as Exhibit 16.1, agreeing with the Company's disclosures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799788/000164117225020843/0001641172-25-020843-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799788/000164117225020843/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-020843

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer